Our results suggest that in SAS patients, the upregulation of IL‐8, ON, and MN may induce a pro‐inflammatory phenotype in muscle tissue, leading to the development of insulin resistance and decreased insulin sensitivity. The gene discussed is CXCL8; the disease is SATB2 associated disorder.